Gilead CEO: ‘We have ample supply’ of remdesivir for hospitalized coronavirus patients

Health, Fitness & Food

Gilead will have enough global supply of its coronavirus treatment remdesivir by the end of October, CEO Daniel O’Day told CNBC on Friday.

Products You May Like

Articles You May Like

White House chief of staff Mark Meadows says ‘we’re not going to control the pandemic’ as coronavirus cases hit record high
Airlines experiment with new routes in ‘game of musical chairs’ to stem billions in pandemic losses
U.S. reports more than 83,000 coronavirus cases, record daily total, as experts warn of difficult winter
Trump claims the worsening U.S. coronavirus outbreak is a ‘Fake News Media Conspiracy’ even as hospitalizations rise
Supply chains will become more local in the pharmaceutical industry, says healthcare CEO

Leave a Reply

Your email address will not be published. Required fields are marked *